BridgeMD
Compares treatment options for Meniscal Extrusion
Official title Transtibial Pull Out Method Versus Suture Anchor Method for Meniscus Extrusion
ClinicalTrials.gov ID: NCT06906783
What this study is testing
- What it's testing
- The concept of meniscal extrusion has recently been recognized as an important pathological condition associated with meniscal dysfunction. Meniscal extrusion is the medial or lateral displacement of the meniscus beyond the edges of the tibial plateau.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Presence of meniscal extrusion greater than 3 mm on MRI scans
- Symptomatic complaints in the knee with extrusion
You likely can't join if
- Malalignment greater than 5 degrees
- Presence of Kellgren-Lawrence grade 3-4 osteoarthritis
The study team makes the final eligibility decision.
Where it's taking place
- Erzurum, Yakutiye, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzurum, Yakutiye, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.